March Expiry
-
{
- All
- News
- Videos
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
Viral Video: Woman Claims To Find Worms In Amul Milk, Company Responds
A viral video from inside a kitchen shows a saucepan full of milk with what appear to be multiple worms in it.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Pakistan Part Ways With Test Head Coach '3 Months Before Expiry Of Contract'
Pakistan Cricket Board (PCB) has parted ways with the national Test team head coach Azhar Mahmood three months before the expiry of his contract, according to sources.
-
Watch: Man Finds 'Worms' Inside Kellogg's Chocos, Company Responds
The product was well within its expiry date (as evidenced by the March 2024 date on the packet's thumbnail).
-
Delhi High Court Seeks CBI's Stand On Former NSE Boss's Bail Plea In Co-Location Case
The CBI had arrested Ms Ramkrishna on March 6, a day after her anticipatory bail application was dismissed by the court. She was remanded to judicial custody on March 14 by the trial court after the expiry of her 7-day CBI custody.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
Viral Video: Woman Claims To Find Worms In Amul Milk, Company Responds
A viral video from inside a kitchen shows a saucepan full of milk with what appear to be multiple worms in it.
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Pakistan Part Ways With Test Head Coach '3 Months Before Expiry Of Contract'
Pakistan Cricket Board (PCB) has parted ways with the national Test team head coach Azhar Mahmood three months before the expiry of his contract, according to sources.
-
Watch: Man Finds 'Worms' Inside Kellogg's Chocos, Company Responds
The product was well within its expiry date (as evidenced by the March 2024 date on the packet's thumbnail).
-
Delhi High Court Seeks CBI's Stand On Former NSE Boss's Bail Plea In Co-Location Case
The CBI had arrested Ms Ramkrishna on March 6, a day after her anticipatory bail application was dismissed by the court. She was remanded to judicial custody on March 14 by the trial court after the expiry of her 7-day CBI custody.
